{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:16:59Z","timestamp":1790864219044,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In this longitudinal study, we describe how psychotropic drugs (PTDs) are prescribed in nursing home (NH) patients from admission and over a 3-year period, to understand which clinical and environmental factors are associated with PTD prescription.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used data from the Resource Use and Disease Course in Dementia \u2013 Nursing Home (REDIC-NH) study, examining physical and mental health, dementia, and PTD prescription during a 3-year period from admission to a NH. Data were collected every six months. At baseline, we included 696 participants from 47 Norwegian NHs. We presented prevalence, incidence, and deprescribing rates of PTD prescriptions for each assessment point. We calculated the odds of receiving PTDs and used a generalized linear mixed model to analyze the variables associated with a change in odds throughout the 3-year period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PTD prescriptions were frequent throughout the 3-year period. Antidepressants had the highest prescription rates (28.4%\u201342.2%). Every PTD category had the highest incidence rate between admission and six months, and antidepressants had the highest values (18.9%). Deprescribing rates were generally highest between baseline and 6-months follow-up, except for sedatives and hypnotics. The odds of antipsychotic prescriptions were lower for older people (OR\u2009=\u20090.96, 95%CI:0.92\u20130.99, <jats:italic>p<\/jats:italic>\u00a0=\u20090.023). People with more severe dementia had lower odds of being prescribed sedatives\/hypnotics (OR\u2009=\u20090.89, 95%CI:0.85\u20130.94, <jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PTDs, particularly antidepressants, are widely prescribed over time to NH patients. Older patients are less likely to receive antipsychotics. A higher severity of dementia decreases the odds of being prescribed sedatives\/hypnotics. Close attention should be paid to PTD prescriptions during long-term NH stay to avoid prolonged and excessive treatment with these types of drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01920100\">NCT01920100<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-021-02437-x","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T12:02:53Z","timestamp":1631793773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Do prescription rates of psychotropic drugs change over three years from nursing home admission?"],"prefix":"10.1186","volume":"21","author":[{"given":"Enrico","family":"Callegari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u016brat\u0117","family":"\u0160altyt\u0117 Benth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Selb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cato","family":"Gr\u00f8nner\u00f8d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"3\u20134","key":"2437_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000433525","volume":"40","author":"AS Helvik","year":"2015","unstructured":"Helvik AS, Engedal K, Benth JS, Selbaek G. Prevalence and severity of dementia in nursing home residents. Dement Geriatr Cogn Disord. 2015;40(3\u20134):166\u201377. https:\/\/doi.org\/10.1159\/000433525.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"10","key":"2437_CR2","doi-asserted-by":"publisher","first-page":"e0206147","DOI":"10.1371\/journal.pone.0206147","volume":"13","author":"AS Helvik","year":"2018","unstructured":"Helvik AS, Selbaek G, Saltyte Benth J, Roen I, Bergh S. The course of neuropsychiatric symptoms in nursing home residents from admission to 30-month follow-up. PLoS One. 2018;13(10):e0206147. https:\/\/doi.org\/10.1371\/journal.pone.0206147.","journal-title":"PLoS One"},{"key":"2437_CR3","first-page":"h369","volume":"350","author":"HC Kales","year":"2015","unstructured":"Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ (Clinical research ed). 2015;350:h369.","journal-title":"BMJ (Clinical research ed)"},{"issue":"6","key":"2437_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1017\/S1041610218001229","volume":"31","author":"RE Brimelow","year":"2019","unstructured":"Brimelow RE, Wollin JA, Byrne GJ, Dissanayaka NN. Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia. Int Psychogeriatr. 2019;31(6):837\u201347. https:\/\/doi.org\/10.1017\/S1041610218001229.","journal-title":"Int Psychogeriatr"},{"key":"2437_CR5","volume-title":"Nasjonal faglig retningslinje om demens","author":"Helsedirektoratet","year":"2017","unstructured":"Helsedirektoratet. Nasjonal faglig retningslinje om demens. Oslo: Helsedirektoratet; 2017. (IS-2658)"},{"issue":"8","key":"2437_CR6","first-page":"Cd003944","volume":"8","author":"R Dudas","year":"2018","unstructured":"Dudas R, Malouf R, McCleery J, Dening T. Antidepressants for treating depression in dementia. Cochrane Database Syst Rev. 2018;8(8):Cd003944.","journal-title":"Cochrane Database Syst Rev"},{"key":"2437_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jclinepi.2018.05.004","volume":"101","author":"CHW Smeets","year":"2018","unstructured":"Smeets CHW, Zuidema SU, Hulshof TA, Smalbrugge M, Gerritsen DL, Koopmans R, et al. Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study. J Clin Epidemiol. 2018;101:17\u201327. https:\/\/doi.org\/10.1016\/j.jclinepi.2018.05.004.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"2437_CR8","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1017\/S1041610211001438","volume":"23","author":"SU Zuidema","year":"2011","unstructured":"Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians\u2019 prescription behavior. Int Psychogeriatr. 2011;23(10):1632\u20139. https:\/\/doi.org\/10.1017\/S1041610211001438.","journal-title":"Int Psychogeriatr"},{"key":"2437_CR9","doi-asserted-by":"crossref","unstructured":"Smeets CHW, Gerritsen DL, Zuidema SU, Teerenstra S, van der Spek K, Smalbrugge M, et al. Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors. Aging Ment Health. 2017:1\u20139.","DOI":"10.1080\/13607863.2017.1348469"},{"issue":"12","key":"2437_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jamda.2013.08.009","volume":"14","author":"CA Lemay","year":"2013","unstructured":"Lemay CA, Mazor KM, Field TS, Donovan J, Kanaan A, Briesacher BA, et al. Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff. J Am Med Dir Assoc. 2013;14(12):895\u2013900. https:\/\/doi.org\/10.1016\/j.jamda.2013.08.009.","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"2437_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jamda.2018.09.030","volume":"19","author":"C Shaw","year":"2018","unstructured":"Shaw C, Williams KN, Perkhounkova Y. Educating nursing home staff in dementia sensitive communication: impact on antipsychotic medication use. J Am Med Dir Assoc. 2018;19(12):1129\u201332. https:\/\/doi.org\/10.1016\/j.jamda.2018.09.030.","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"2437_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1017\/S1041610216001897","volume":"29","author":"SI Janus","year":"2017","unstructured":"Janus SI, van Manen JG, IJzerman MJ, Bisseling M, Drossaert CH, Zuidema SU. Determinants of the nurses\u2019 and nursing assistants\u2019 request for antipsychotics for people with dementia. Int Psychogeriatr. 2017;29(3):475\u201384. https:\/\/doi.org\/10.1017\/S1041610216001897.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"2437_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/psyg.12280","volume":"18","author":"SIM Janus","year":"2018","unstructured":"Janus SIM, van Manen JG, Zuidema SU, Snijder C, Drossaert CHC, Ijzerman MJ. Reasons for (not) discontinuing antipsychotics in dementia. Psychogeriatrics. 2018;18(1):13\u201320. https:\/\/doi.org\/10.1111\/psyg.12280.","journal-title":"Psychogeriatrics."},{"issue":"5","key":"2437_CR14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s11096-016-0337-y","volume":"38","author":"FA da Costa","year":"2016","unstructured":"da Costa FA, Periquito C, Carneiro MC, Oliveira P, Fernandes AI, Cavaco-Silva P. Potentially inappropriate medications in a sample of Portuguese nursing home residents: does the choice of screening tools matter? Int J Clin Pharm. 2016;38(5):1103\u201311. https:\/\/doi.org\/10.1007\/s11096-016-0337-y.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"2437_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/02813432.2015.1041833","volume":"33","author":"G Nyborg","year":"2015","unstructured":"Nyborg G, Straand J, Klovning A, Brekke M. The Norwegian general practice--nursing home criteria (NORGEP-NH) for potentially inappropriate medication use: a web-based Delphi study. Scand J Prim Health Care. 2015;33(2):134\u201341. https:\/\/doi.org\/10.3109\/02813432.2015.1041833.","journal-title":"Scand J Prim Health Care"},{"issue":"4","key":"2437_CR16","first-page":"570","volume":"21","author":"M Mihanovi\u0107","year":"2009","unstructured":"Mihanovi\u0107 M, Bodor D, Kezi\u0107 S, Restek-Petrovi\u0107 B, Sili\u0107 A. Differential diagnosis of psychotropic side effects and symptoms and signs of psychiatric disorders. Psychiatr Danub. 2009;21(4):570\u20134.","journal-title":"Psychiatr Danub"},{"issue":"5","key":"2437_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s41999-019-00279-w","volume":"11","author":"K El Haddad","year":"2020","unstructured":"El Haddad K, de Souto BP, de Mazieres CL, Rolland Y. Effect of a geriatric intervention aiming to improve polypharmacy in nursing homes. Eur Geriatr Med. 2020;11(5):863\u20138.","journal-title":"Eur Geriatr Med"},{"issue":"4","key":"2437_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345\u201351. https:\/\/doi.org\/10.1016\/j.amjopharm.2007.12.002.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"9","key":"2437_CR19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1017\/S1041610213000859","volume":"25","author":"M Gustafsson","year":"2013","unstructured":"Gustafsson M, Sandman PO, Karlsson S, Gustafson Y, Lovheim H. Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings. Int Psychogeriatr. 2013;25(9):1415\u201323. https:\/\/doi.org\/10.1017\/S1041610213000859.","journal-title":"Int Psychogeriatr"},{"issue":"10","key":"2437_CR20","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1111\/jgs.15016","volume":"65","author":"LC Maclagan","year":"2017","unstructured":"Maclagan LC, Maxwell CJ, Gandhi S, Guan J, Bell CM, Hogan DB, et al. Frailty and Potentially Inappropriate Medication Use at Nursing Home Transition. J Am Geriatr Soc. 2017;65(10):2205\u201312.","journal-title":"J Am Geriatr Soc"},{"key":"2437_CR21","doi-asserted-by":"publisher","unstructured":"Selbaek G, Janus SIM, Bergh S, Engedal K, Ruths S, Helvik AS, et al. Change in psychotropic drug use in Norwegian nursing homes between 2004 and 2011. Int Psychogeriatr. 2017:1\u201310.\u00a0https:\/\/doi.org\/10.1017\/s1041610217001788.","DOI":"10.1017\/s1041610217001788"},{"issue":"1","key":"2437_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12877-017-0440-5","volume":"17","author":"AS Helvik","year":"2017","unstructured":"Helvik AS, Saltyte Benth J, Wu B, Engedal K, Selbaek G. Persistent use of psychotropic drugs in nursing home residents in Norway. BMC Geriatr. 2017;17(1):52. https:\/\/doi.org\/10.1186\/s12877-017-0440-5.","journal-title":"BMC Geriatr"},{"issue":"3","key":"2437_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/gps.1453","volume":"21","author":"P Scocco","year":"2006","unstructured":"Scocco P, Rapattoni M, Fantoni G. Nursing home institutionalization: a source of eustress or distress for the elderly? Int J Geriatr Psychiatry. 2006;21(3):281\u20137. https:\/\/doi.org\/10.1002\/gps.1453.","journal-title":"Int J Geriatr Psychiatry."},{"key":"2437_CR24","first-page":"1469","volume":"121","author":"HA Nygaard","year":"2001","unstructured":"Nygaard HA. Chronisity of drug treatment in nursing home residents. Tidsskr Nor L\u00e6geforen 2001. 2001;121:1469\u201371.","journal-title":"Tidsskr Nor L\u00e6geforen 2001"},{"issue":"7","key":"2437_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1017\/S1041610210000165","volume":"22","author":"DW O'Connor","year":"2010","unstructured":"O'Connor DW, Griffith J, McSweeney K. Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia. Intern Psychogeriatr. 2010;22(7):1149\u201353. https:\/\/doi.org\/10.1017\/S1041610210000165.","journal-title":"Intern Psychogeriatr"},{"issue":"3","key":"2437_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/02813432.2012.704813","volume":"30","author":"MS Bakken","year":"2012","unstructured":"Bakken MS, Ranhoff AH, Engeland A, Ruths S. Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. Scand J Prim Health Care. 2012;30(3):169\u201375. https:\/\/doi.org\/10.3109\/02813432.2012.704813.","journal-title":"Scand J Prim Health Care"},{"key":"2437_CR27","first-page":"w13254","volume":"141","author":"I Lustenberger","year":"2011","unstructured":"Lustenberger I, Schupbach B, von Gunten A, Mosimann U. Psychotropic medication use in Swiss nursing homes. Swiss Med Wkly. 2011;141:w13254.","journal-title":"Swiss Med Wkly"},{"key":"2437_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.archger.2018.01.005","volume":"75","author":"I Ivanova","year":"2018","unstructured":"Ivanova I, Wauters M, Stichele RV, Christiaens T, De Wolf J, Dilles T, et al. Medication use in a cohort of newly admitted nursing home residents (ageing@NH) in relation to evolving physical and mental health. Arch Gerontol Geriatr. 2018;75:202\u20138. https:\/\/doi.org\/10.1016\/j.archger.2018.01.005.","journal-title":"Arch Gerontol Geriatr"},{"key":"2437_CR29","doi-asserted-by":"publisher","unstructured":"Callegari E, Benth J, Selb\u00e6k G, Gr\u00f8nner\u00f8d C, Bergh S. Does Psychotropic Drug Prescription Change in Nursing Home Patients the First 6 Months After Admission? J Am Med Dir Assoc. 2020;22(1):101\u20138.e1. https:\/\/doi.org\/10.1016\/j.jamda.2020.08.034.","DOI":"10.1016\/j.jamda.2020.08.034"},{"issue":"12","key":"2437_CR30","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308\u201314. https:\/\/doi.org\/10.1212\/WNL.44.12.2308.","journal-title":"Neurology."},{"issue":"1","key":"2437_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12913-017-2289-x","volume":"17","author":"I Roen","year":"2017","unstructured":"Roen I, Selbaek G, Kirkevold O, Engedal K, Testad I, Bergh S. Resourse use and disease Couse in dementia - nursing home (REDIC-NH), a longitudinal cohort study; design and patient characteristics at admission to Norwegian nursing homes. BMC Health Serv Res. 2017;17(1):365. https:\/\/doi.org\/10.1186\/s12913-017-2289-x.","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"2437_CR32","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134. https:\/\/doi.org\/10.1212\/wnl.43.11.2412-a.","journal-title":"Neurology."},{"issue":"3","key":"2437_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist. 1969;9(3):179\u201386. https:\/\/doi.org\/10.1093\/geront\/9.3_Part_1.179.","journal-title":"The Gerontologist"},{"issue":"3","key":"2437_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","volume":"23","author":"GS Alexopoulos","year":"1988","unstructured":"Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271\u201384. https:\/\/doi.org\/10.1016\/0006-3223(88)90038-8.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"2437_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1532-5415.1999.tb07245.x","volume":"47","author":"CG Lyketsos","year":"1999","unstructured":"Lyketsos CG, Galik E, Steele C, Steinberg M, Rosenblatt A, Warren A, et al. The general medical health rating: a bedside global rating of medical comorbidity in patients with dementia. J Am Geriatr Soc. 1999;47(4):487\u201391. https:\/\/doi.org\/10.1111\/j.1532-5415.1999.tb07245.x.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"2437_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"3","key":"2437_CR37","first-page":"114","volume":"1","author":"MF Weiner","year":"2000","unstructured":"Weiner MF, Martin-Cook K, Svetlik DA, Saine K, Foster B, Fontaine CS. The quality of life in late-stage dementia (QUALID) scale. J Am Med Dir Assoc. 2000;1(3):114\u20136.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"2437_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12877-016-0287-1","volume":"16","author":"C Gulla","year":"2016","unstructured":"Gulla C, Selbaek G, Flo E, Kjome R, Kirkevold O, Husebo BS. Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011. BMC Geriatr. 2016;16(1):115. https:\/\/doi.org\/10.1186\/s12877-016-0287-1.","journal-title":"BMC Geriatr"},{"issue":"2","key":"2437_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jamda.2013.09.012","volume":"15","author":"B Afram","year":"2014","unstructured":"Afram B, Stephan A, Verbeek H, Bleijlevens MH, Suhonen R, Sutcliffe C, et al. Reasons for institutionalization of people with dementia: informal caregiver reports from 8 European countries. J Am Med Dir Assoc. 2014;15(2):108\u201316. https:\/\/doi.org\/10.1016\/j.jamda.2013.09.012.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"2437_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1017\/S2045796015001171","volume":"26","author":"J Damian","year":"2017","unstructured":"Damian J, Pastor-Barriuso R, Valderrama-Gama E, de Pedro-Cuesta J. Association of detected depression and undetected depressive symptoms with long-term mortality in a cohort of institutionalised older people. Epidemiol Psychiatr Sci. 2017;26(2):189\u201398. https:\/\/doi.org\/10.1017\/S2045796015001171.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"1\u20133","key":"2437_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jad.2009.04.028","volume":"120","author":"ML Barca","year":"2010","unstructured":"Barca ML, Engedal K, Laks J, Selbaek G. A 12 months follow-up study of depression among nursing-home patients in Norway. J Affect Disord. 2010;120(1\u20133):141\u20138. https:\/\/doi.org\/10.1016\/j.jad.2009.04.028.","journal-title":"J Affect Disord"},{"key":"2437_CR42","doi-asserted-by":"publisher","unstructured":"Resnick B, Kolanowski A, Van Haitsma K, Galik E, Boltz M, Ellis J, et al. Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment. Clin Nurs Res. 2019;30(1):59\u201369. https:\/\/doi.org\/10.1177\/1054773819838678.","DOI":"10.1177\/1054773819838678"},{"issue":"4","key":"2437_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00006199-200607000-00005","volume":"55","author":"H Kim","year":"2006","unstructured":"Kim H, Whall AL. Factors associated with psychotropic drug usage among nursing home residents with dementia. Nurs Res. 2006;55(4):252\u20138. https:\/\/doi.org\/10.1097\/00006199-200607000-00005.","journal-title":"Nurs Res"},{"issue":"1","key":"2437_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.amjopharm.2011.12.005","volume":"10","author":"J Tjia","year":"2012","unstructured":"Tjia J, Gurwitz JH, Briesacher BA. Challenge of changing nursing home prescribing culture. Am J Geriatr Pharmacother. 2012;10(1):37\u201346. https:\/\/doi.org\/10.1016\/j.amjopharm.2011.12.005.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"2437_CR45","doi-asserted-by":"publisher","first-page":"e1002500","DOI":"10.1371\/journal.pmed.1002500","volume":"15","author":"C Ballard","year":"2018","unstructured":"Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, et al. Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial. PLoS Med. 2018;15(2):e1002500. https:\/\/doi.org\/10.1371\/journal.pmed.1002500.","journal-title":"PLoS Med"},{"key":"2437_CR46","volume-title":"National Partnership to Improve Dementia Care in Nursing Homes: Antipsychotic Medication Use Data Report","author":"The U.S. Centers for Medicare & Medicaid Services","year":"2020","unstructured":"The U.S. Centers for Medicare & Medicaid Services. National Partnership to Improve Dementia Care in Nursing Homes: Antipsychotic Medication Use Data Report. 2020."},{"issue":"7","key":"2437_CR47","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/gps.5106","volume":"34","author":"JM Randle","year":"2019","unstructured":"Randle JM, Heckman G, Oremus M, Ho J. Intermittent antipsychotic medication and mortality in institutionalized older adults: a scoping review. Int J Geriatr Psychiatry. 2019;34(7):906\u201320. https:\/\/doi.org\/10.1002\/gps.5106.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"15","key":"2437_CR48","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa061240","volume":"355","author":"LS Schneider","year":"2006","unstructured":"Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer\u2019s disease. N Engl J Med. 2006;355(15):1525\u201338. https:\/\/doi.org\/10.1056\/NEJMoa061240.","journal-title":"N Engl J Med"},{"issue":"10","key":"2437_CR49","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/gps.3934","volume":"28","author":"E Bartfay","year":"2013","unstructured":"Bartfay E, Bartfay WJ, Gorey KM. Prevalence and correlates of potentially undetected dementia among residents of institutional care facilities in Ontario, Canada, 2009-2011. Int J Geriatr Psychiatry. 2013;28(10):1086\u201394. https:\/\/doi.org\/10.1002\/gps.3934.","journal-title":"Int J Geriatr Psychiatry."},{"key":"2437_CR50","doi-asserted-by":"publisher","first-page":"925702","DOI":"10.1155\/2013\/925702","volume":"2013","author":"I Molino","year":"2013","unstructured":"Molino I, Colucci L, Fasanaro AM, Traini E, Amenta F. Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer's disease: a review of clinical trials. ScientificWorldJournal. 2013;2013:925702.","journal-title":"ScientificWorldJournal."},{"issue":"7","key":"2437_CR51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/ijnp\/pyx012","volume":"20","author":"L Blanco-Silvente","year":"2017","unstructured":"Blanco-Silvente L, Castells X, Saez M, Barcel\u00f3 MA, Garre-Olmo J, Vilalta-Franch J, et al. Discontinuation, efficacy, and safety of cholinesterase inhibitors for Alzheimer\u2019s disease: a Meta-analysis and Meta-regression of 43 randomized clinical trials enrolling 16 106 patients. Int J Neuropsychopharmacol. 2017;20(7):519\u201328. https:\/\/doi.org\/10.1093\/ijnp\/pyx012.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"may18 1","key":"2437_CR52","doi-asserted-by":"publisher","first-page":"e2809","DOI":"10.1136\/bmj.e2809","volume":"344","author":"EA Akl","year":"2012","unstructured":"Akl EA, Briel M, You JJ, Sun X, Johnston BC, Busse JW, et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ : British Medical Journal. 2012;344(may18 1):e2809. https:\/\/doi.org\/10.1136\/bmj.e2809.","journal-title":"BMJ : British Medical Journal"}],"updated-by":[{"DOI":"10.1186\/s12877-022-03486-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000}}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-021-02437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-021-02437-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-021-02437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:03:51Z","timestamp":1671725031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-021-02437-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2437"],"URL":"https:\/\/doi.org\/10.1186\/s12877-021-02437-x","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"11 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12877-022-03486-6","URL":"https:\/\/doi.org\/10.1186\/s12877-022-03486-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For participation, a signed informed consent was needed. NH personnel assessed the patients\u2019 capacity to consent to participate in the study. For patients with a clear capacity to consent, a signed informed consent was collected directly from the participants, but not from their next of kin. For patients with no capacity to consent, a signed informed consent from the participants\u2019 next of kin was collected. The Regional Committee for Medical and Health Research Ethics in South-Eastern Norway approved the study (2011\/1738). The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GS has received honoraria for participating in a meeting of the Norwegian advisory board for Biogen, regarding the aducanumab trials. The other named authors have no competing interests, financial or otherwise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"496"}}